Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Staph Aureus Methicillin Resistant Bacteremia”

Showing 2 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05329168
What this trial is testing

ERAdicate S. Aureus in Patients With Bacteremia and Endocarditis

Who this might be right for
Bacteremia Due to Staphylococcus AureusLeft Sided Infective Endocarditis (Disorder)Right Sided Infective Endocarditis (Disorder)+1 more
Lysovant
Testing effectiveness (Phase 2)Ended earlyNCT00695903
What this trial is testing

Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia

Who this might be right for
Endocarditis, BacterialInfective Endocarditis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 38

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation